Giving early discovery every advantage for success
Our focus is on supporting emerging pharmaceutical, medical device, consumer and digital health companies through the tenuous time between early discovery and having the necessary resources to move a product through the path to commercialization. We give companies every tangible advantage to succeed, providing access to core research facilities hosting specialized capital equipment, educational programs, operational capabilities and a community of like-minded entrepreneurs. We also provide access to Johnson & Johnson Innovation deal teams expanding opportunities for venture capital funding, as well as the deal-making, therapeutic and technology area, product development and commercialization expertise of Johnson & Johnson. Therapeutic areas of focus include oncology, immunology, neuroscience, cardiovascular and metabolism, infectious diseases and vaccines.